Antitumoral RNA‐targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies

Oligonucleotide therapeutics, drugs consisting of 10–50 nucleotide‐long single‐ or double‐stranded DNA or RNA molecules that can bind to specific DNA or RNA sequences or proteins, include antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), microRNAs (miRNAs), aptamers, and decoys. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Hiroaki, Suzuki, Yasunori, Imai, Kohzoh, Adachi, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459246/
https://www.ncbi.nlm.nih.gov/pubmed/35701833
http://dx.doi.org/10.1111/cas.15461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459246/
https://www.ncbi.nlm.nih.gov/pubmed/35701833
http://dx.doi.org/10.1111/cas.15461

Ejemplares similares